Imperial College London

Dr Paul F. McKay

Faculty of MedicineDepartment of Infectious Disease

Senior Research Fellow
 
 
 
//

Contact

 

+44 (0)20 7594 2542p.mckay

 
 
//

Location

 

125 (Shattock Group)Wright Fleming WingSt Mary's Campus

//

Summary

 

Summary

Dr Paul McKay is a senior researcher working within Professor Robin Shattock’s mucosal vaccinology team in the Department of Medicine. His primary research centres on the development of new vaccine candidates, the optimization of immunization regimens and the assessment of potential vaccine efficacy, with a particular focus on the generation of vaccine-induced immunity at the surface and within mucosal tissue.

Paul was awarded a B.Sc. (Hons) in Biochemistry from Imperial College, then a M.Sc. in Medical Immunology from The Royal Postgraduate Medical School (now the Hammersmith Campus of Imperial College, London) and finally a Ph.D. in Molecular Immunology, also from Imperial College.  He then spent four years at Harvard Medical School and the Beth Israel Deaconess Medical Centre in Boston, USA, working for Professor Norman Letvin on the characterization of T cell responses to various vaccine modalities and the analysis, development and optimization of DNA prime and recombinant vector boost HIV vaccine candidates. He returned to the UK to work at St. George’s, University of London and was part of a successful application to the Bill and Melinda Gates Foundation and The Wellcome Trust for a Grand Challenges for Global Health Initiative program grant to optimize vaginal vaccination against HIV infection.

Paul is currently involved in a number of research programs awarded to Professor Robin Shattock and funded by CHAVI, the Center for HIV AIDS Vaccine Immunology funded by NIH, the EUROPRISE Network of Excellence on Vaccines and Microbicides, the Bill and Melinda Gates Grand Challenges for Global Health ‘Novel Antigen Design and Delivery for Mucosal Protection Against HIV-1 Infection’ initiative. He also holds a Sir Joseph Hotung Senior Fellowship and is based at St. George’s, University of London and Imperial College, London. He lectures on vaccine design and development and on T cell and Dendritic Cell biology and has successfully supervised a number of M.Sc., M.Res and Ph.D. students.

Grand Challenges in Global Health  UK HVC   EUROPRISE

Publications

Journals

Pinder CL, McKay PF, Shattock RJ, 2021, Use of chlamydial elementary bodies as probes to isolate pathogen-specific human monoclonal antibodies., Methods in Molecular Biology, Vol:2183, ISSN:1064-3745, Pages:19-28

Siris S, Gladstone CA, Guo Y, et al., 2021, Isolating Pathogen-Specific Human Monoclonal Antibodies (hmAbs) Using Bacterial Whole Cells as Molecular Probes., Methods Mol Biol, Vol:2183, Pages:9-18

Blakney A, McKay P, Bouton C, et al., 2020, Innate inhibiting proteins enhance expression and immunogenicity of self-amplifying RNA, Molecular Therapy, ISSN:1525-0016

J C, Najer A, Blakney A, et al., 2020, Neutrophils enable local and non-invasive liposome delivery to inflamed skeletal muscle and ischemic heart, Advanced Materials, ISSN:0935-9648

Gurnani P, Blakney AK, Terracciano R, et al., 2020, The In Vitro, Ex Vivo, and In Vivo Effect of Polymer Hydrophobicity on Charge-Reversible Vectors for Self-Amplifying RNA, Biomacromolecules, Vol:21, ISSN:1525-7797, Pages:3242-3253

More Publications